B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Crossref DOI link: https://doi.org/10.1186/s13075-016-1166-z
Published Online: 2016-11-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bruijnen, Stefan http://orcid.org/0000-0003-2155-4929
Tsang-A-Sjoe, Michel
Raterman, Hennie
Ramwadhdoebe, Tamara
Vugts, Daniëlle
van Dongen, Guus
Huisman, Marc
Hoekstra, Otto
Tak, Paul-Peter
Voskuyl, Alexandre
van der Laken, Conny